Abiopharma

AtaiBeckley Provides Update and Outlook for 2026 Ahead of J.P. Morgan Healthcare Conference

Lexeo Therapeutics Announces Research Collaboration to Explore Targeted Cardiac Delivery of AAV Gene Therapy

Entrada Therapeutics Highlights Progress Across its Portfolio of RNA-based Therapeutics for the Treatment of Neuromuscular and Ocular Diseases

(10% Negative) TELEFLEX INCORPORATED (TFX) Announces Business Combination

NervGen Pharma Begins Trading on Nasdaq Today

Teleflex - Teleflex Announces Leadership Transition

Teleflex Announces Leadership Transition

Pharming Group N.V. (PHAR) Files Form 6-K

New Form 424B3 - Celularity Inc Filed: 2026-01-08 AccNo: 0001493152-26-000878 Size: 304 KB

New Form FWP - ARROWHEAD PHARMACEUTICALS, INC. Filed: 2026-01-08 AccNo: 0001193125-26-006942 Size: 65 KB

Grifols Communication - Laura de la Cruz appointed as the new Secretary non-member of the Board of Directors

AstraZeneca Plc (AZNCF) Files Form 6-K

New Form EFFECT - Vivos Therapeutics, Inc. Filed: 2026-01-07 AccNo: 9999999995-26-000088 Size: 1 KB

New Form EFFECT - SAB Biotherapeutics, Inc. Filed: 2026-01-07 AccNo: 9999999995-26-000101 Size: 1 KB

New Form EFFECT - PRECISION BIOSCIENCES INC Filed: 2026-01-07 AccNo: 9999999995-26-000100 Size: 1 KB